You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 26, 2024

Details for Patent: 9,770,441


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,770,441 protect, and when does it expire?

Patent 9,770,441 protects VYNDAMAX and is included in one NDA.

This patent has thirty-one patent family members in twenty-two countries.

Summary for Patent: 9,770,441
Title:Crystalline solid forms of 6-carboxy-2-(3,5-dichlorophenyl)-benzoxazole
Abstract: The present invention relates to solid forms of 6-carboxy-2-(3,5-dichlorophenyl)-benzoxazole and to methods for their preparation. The invention is also directed to pharmaceutical compositions containing at least one solid form and to the therapeutic or prophylactic use of such solid forms and compositions.
Inventor(s): Girard; Kevin Paul (Quaker Hill, CT), Jensen; Andrew J. (Ledyard, CT), Jones; Kris Nicole (Waterford, CT)
Assignee: Pfizer Inc. (New York, NY)
Application Number:15/509,343
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 9,770,441
Patent Claim Types:
see list of patent claims
Use; Composition; Compound;

Drugs Protected by US Patent 9,770,441

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Foldrx Pharms VYNDAMAX tafamidis CAPSULE;ORAL 212161-001 May 3, 2019 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y Y TREATMENT OF THE CARDIOMYOPATHY OF WILD TYPE OR HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS (ATTR-CM) ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 9,770,441

PCT Information
PCT FiledAugust 31, 2015PCT Application Number:PCT/IB2015/056597
PCT Publication Date:March 17, 2016PCT Publication Number: WO2016/038500

International Family Members for US Patent 9,770,441

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 101778 ⤷  Try a Trial
Australia 2015313875 ⤷  Try a Trial
Brazil 112017003421 ⤷  Try a Trial
Canada 2903194 ⤷  Try a Trial
China 106715405 ⤷  Try a Trial
China 115368313 ⤷  Try a Trial
Cyprus 1124843 ⤷  Try a Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.